Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial

BACKGROUND: Cotrimoxazole (CTX) preventive therapy (CPT) reduces opportunistic infections and malaria in HIV-infected patients. In Africa, policies on sustained CPT during antiretroviral therapy (ART) differ between countries. We assessed the safety of discontinuing CPT in stable patients on ART in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Anywaine, Zacchaeus, Levin, Jonathan, Kasirye, Ronnie, Lutaakome, Joseph Kayiira, Abaasa, Andrew, Nunn, Andrew, Grosskurth, Heiner, Munderi, Paula
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6312229/
https://ncbi.nlm.nih.gov/pubmed/30596666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0206907
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi